X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214463
https://www.contractpharma.com/contents/view_breaking-news/2022-05-11/neuvivo-begins-manufacture-of-als-treatment-np001/?widget=listSection
https://news.cision.com/oxcia-ab--publ-/r/oxcia-contracts-patheon-for-manufacturing-and-further-strengthens-the-organization,c3486875#:~:text=Oxcia%20contracts%20Patheon%20for%20manufacturing%20and%20further%20strengthens%20the%20organization,-Mon%2C%20Jan%2017&text=OXC%2D101%20is%20Oxcia's%20first,solid%20cancers%20or%20blood%20cancers.
https://www.contractpharma.com/contents/view_breaking-news/2020-07-17/patheon-to-manufacture-fda-approved-nasal-spray/
https://www.fiercepharma.com/manufacturing/tergus-pharma-to-become-full-fledged-cdmo-new-manufacturing-facility
https://www.fiercebiotech.com/medtech/thermo-fisher-picks-up-mass-spec-software-developer-highchem
https://www.contractpharma.com/contents/view_breaking-news/2019-05-20/cantargia-patheon-biologics-sign-supply-agreement/
https://www.ema.europa.eu/documents/scientific-guideline/overview-comments-received-ibuprofen-200-800-mg-oral-use-immediate-release-formulations-product_en.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-14-2018-1521002669.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-7-2018-1520410330.pdf
Market Place
Share 
